BIOMIMESYS® 3D technology is a natural HA-based scaffold to better mimic the tissue microenvironment and provide more predictive tools for drug development. The BIOMIMESYS® products are formed by crosslinking reaction of hydrosoluble modified hyaluronic acid and others matrix components with ADH (adipic acid dihydrazide), to mimic the extracellular matrix (ECM). Depending on the organ, ECM components vary and are present in different proportions, allowing a more or less dense and compact cellular environment. BIOMIMESYS® 3D technology allows us to reproduce the cell microenvironment of each organ.
Click here to get more information!
To ensure personalised treatment for familial hypercholesterolemia
To develop relevant 3D models of different tumors, in order to better assess the efficiency of anticancer therapies.
A holistic approach to address brain delivery
Face to the high failure of drug candidate in clinical trial, in particular involving the brain, we goal to develop more relevant and more predictive in vitro models for preclinical assessment, in the aim to early select molecules of interest, in term of efficacy and safety.
To design and industrialize new pharmacological in vitro assays for the screening of compounds/biopharmaceuticals in 3D
To develop the technological platform to produce lab-grown meats. The project is funded by EUREKA and the national funding agencies associated with the Eurostars program.
To develop a universal “plug-and-play” liver-on-chip platform mimicking the major events occurring in the liver sinusoid in order to predict the hepatoxicity of drugs.
To explore the use of AI technologies to improve different steps of 3D biological picture exploitation
The extracellular matrix (ECM) is the non-cellular component of tissue. Its composition and structure can vary between different tissues. The ECM transmits biochemical and biomechanical cues to the cells within it, ensuring tissue homeostasis. The Read more…
When Tuesday, April 20, 2021 – 1PM (CET) / 8PM (CST) / 9PM (JST) / 7AM (EST) Thursday, April 22, 2021 – 9AM (CET) / 4PM (CST) / 5PM (JST) / 3AM (EST) Where Online, using zoom.us Read more…
We are very happy to welcome Lucille in our laboratory. Lucille is currently finishing a master degree in Biotechnologies at AgroParisTech, a French engineering school. During her studies, she had the opportunity to work with Read more…
We are very happy to invite you to our next webinar about 3D cellular cancer models and our BIOMIMESYS® Oncology matrix which allows cancer cells to be cultured in a tumor-like environment, with the possibility Read more…
3D cell culture systems have recently emerged as promising tools for reproducing the cellular environment and the organization of tissues/organs, where cells are connected to each other and to the surrounding extracellular matrix (ECM). In Read more…
Few weeks ago, the Hong Kong–based company Insilico Medicine announced the beginning of a phase 1 clinical trial concerning a potential therapy for idiopathic pulmonary fibrosis. The event might have gone unnoticed but the way Read more…
Cultivated meat is meat produced from cells cultures, and it appears as a promising alternative to traditional meat derived from animals. Sometimes known as clean meat, cultured meat or in vitro meat, such cells are Read more…
It was a great pleasure to present our technology BIOMIMESYS for relevant 3D cell cultures, and its applications in oncology field in the frame of ONCOLille seminars. All the questions and discussions at the end Read more…
During the next Molecular Devices online event called “From organoids to cell painting: Investigate 3D and complex biology using advanced methods in high-content cellular imaging and analysis” we will present how to generate functional human Read more…
Durée : environ 10 semaines (début possible avril 2021) Lieu : HCS Pharma, Parc Eurasanté, Loos (59) + travail à distance (suivant conditions sanitaires) Missions : Au sein d’ HCS Pharma vous travaillerez sur la Read more…
When Tuesday, March 23, 2021 – 1PM (CET) / 8PM (CST) / 9PM (JST) / 7AM (EST) Thursday, March 25, 2021 – 9AM (CET) / 4PM (CST) / 5PM (JST) / 3AM (EST) Where Online, using zoom.us Read more…
3D cell culture systems have recently as promising tools for reproducing the cellular environment and the organization of tissues/organs, where cells are connected to each other and to the surrounding extracellular matrix (ECM). Join us Read more…
The skin microbiota refers to the microorganisms living on the skin, on the surface of the epidermis, but also in the dermis and the hypodermis (Nakatsuji et al., 2013). On 1 cm2 of human skin, Read more…
Nous sommes heureux de vous annoncer que le Ministère de l’Enseignement Supérieur et de la Recherche a accordé à HCS Pharma l’agrément au Crédit d’Impôt Recherche (CIR) jusqu’en 2023, en regard de nos activités de R&D. Read more…
We are glad to share with you confocal microscopy pictures showing the interactions between two proteins (complexes are the red spots) at the surface of breast cancer cells (MDA-MB-231) cultivated in 3D in BIOMIMESYS matrix. Read more…
HCS Pharma – Siège de Lille
Biocentre Fleming Bat A
250 rue Salvador Allende
59120 LOOS
See on map
+33 769 999 137
Only for customers please, if you have another interest use the form contact.